Canada markets open in 37 minutes

Regulus Therapeutics Inc. (RGLS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3400-0.2200 (-8.59%)
At close: 04:00PM EDT
2.2874 -0.05 (-2.25%)
Pre-Market: 08:39AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
10,006
Operating Expenses
Research Development
21,152
21,152
18,410
17,794
15,347
Selling General and Administrative
9,957
9,957
9,829
10,022
8,814
Total Operating Expenses
31,109
31,109
28,239
27,816
24,161
Operating Income or Loss
-31,109
-31,109
-28,239
-27,816
-14,155
Interest Expense
604
604
688
855
1,808
Income Before Tax
-30,036
-30,036
-28,322
-27,807
-15,730
Income Tax Expense
1
1
1
1
0
Income from Continuing Operations
-30,037
-30,037
-28,323
-27,808
-15,730
Net Income
-30,037
-30,037
-28,323
-27,808
-15,730
Net Income available to common shareholders
-30,037
-30,037
-28,323
-27,808
-15,730
Basic EPS
-1.59
-
-1.86
-3.24
-4.50
Diluted EPS
-1.59
-
-1.86
-3.24
-4.50
Basic Average Shares
18,116
-
15,260
8,570
3,498
Diluted Average Shares
18,116
-
15,260
8,570
3,498